Profiles

Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.

Stage 3: Technically Confirmed Profiles

• FDG-PET/CT for Response to Cancer Therapy 2016-11-18

Stage 2: Consensus Profiles

• CT Tumor Volumetry for Advanced Disease 2016-11-21b

• Checklist - CT Tumor Volumetry for Advanced Disease

Stage 1: Public Comment Profiles

• QIBA PET Amyloid Profile 2017-06-15 (Public Comment Form: http://tinyurl.com/y8dy2pc2)

 (Public Comment is open for 90 days - until September 15, 2017)

• DWI Profile 2017-04-27 (Public Comment Form: https://goo.gl/fkL6rB)
• DCE-MRI Quantification 2011-12-13 (Public Comment ended Feb 2012)
• Quantifying Dopamine Transporters with 123 - Iodine Labeled Ioflupane in Neurodegenerative Disease Profile (v1.0), October 28, 2016

• Checklist: SPECT Profile Conformance

Statements of Endorsement

• Industry
• Clinical Sites
• Additional letters of support can be found here

See Also

• How to use QIBA Profiles
• Biomarker Committee pages may also have links to DRAFT Profile documents for the next Stage.
• Profile Conformance describes how sites and products claim conformance to a Profile.
• QIBA Profile Template shows the structure, rationale and content of a Profile (show "All Markup" to see guidance in the Word comments)

• Work Product for Review